Role of EBUS-TBNA/EUS-FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10-year experience in two tertiary care academic centers.
Asghar NaqviMichael BonertChristian FinleyKatarzyna Czarnecka-KujawaKazuhiro YasufukuJoerg SchwockVathany KulasingamRohan JohnHyang Mi KoPublished in: Cancer cytopathology (2023)
EBUS-TBNA/EUS-FNA is effective for amyloidosis diagnosis and provides adequate material for ancillary tests, including MS, which can identify the precursor amyloidogenic protein, leading to appropriate patient management.